EyePoint Pharmaceuticals, Inc. Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
EyePoint Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
  • EyePoint Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2024 was -31.6 %, a 47% increase year-over-year.
  • EyePoint Pharmaceuticals, Inc. annual Return On Assets for 2023 was -33.5 %, a 28% increase from 2022.
  • EyePoint Pharmaceuticals, Inc. annual Return On Assets for 2022 was -46.5 %, a 58.8% decline from 2021.
  • EyePoint Pharmaceuticals, Inc. annual Return On Assets for 2021 was -29.3 %, a 48.6% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -33.5 +13.1 +28% Jan 1, 2023 Dec 31, 2023
2022 -46.5 -17.2 -58.8% Jan 1, 2022 Dec 31, 2022
2021 -29.3 +27.7 +48.6% Jan 1, 2021 Dec 31, 2021
2020 -57 +12.8 +18.4% Jan 1, 2020 Dec 31, 2020
2019 -69.9 +49.4 +41.4% Jan 1, 2019 Dec 31, 2019
2018 -119 -27.8 -30.4% Jan 1, 2018 Dec 31, 2018
2017 -91.4 -19.1 -26.5% Jul 1, 2016 Jun 30, 2017
2016 -72.3 -89 -533% Jul 1, 2015 Jun 30, 2016
2015 16.7 +74.6 Jul 1, 2014 Jun 30, 2015
2014 -57.9 +1.78 +2.98% Jul 1, 2013 Jun 30, 2014
2013 -59.7 +29.4 +33% Jul 1, 2012 Jun 30, 2013
2012 -89.1 Jul 1, 2011 Jun 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.